1 Mortality |
15 |
1323 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.93, 1.44] |
1.1 Glucocorticosteroid avoidance |
9 |
758 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.84, 1.48] |
1.2 Glucocorticosteroid withdrawal |
6 |
565 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.22 [0.86, 1.72] |
2 Graft loss including death |
11 |
1002 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.90, 1.46] |
2.1 Glucocorticosteroid avoidance |
8 |
671 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.03 [0.77, 1.39] |
2.2 Glucocorticosteroid withdrawal |
3 |
331 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.44 [0.93, 2.24] |
3 Acute rejection |
16 |
1347 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.33 [1.08, 1.64] |
3.1 Glucocorticosteroid avoidance |
10 |
782 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.37 [1.04, 1.81] |
3.2 Glucocorticosteroid withdrawal |
6 |
565 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.28 [0.93, 1.76] |
4 Infection |
8 |
778 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.73, 1.05] |
4.1 Glucocorticosteroid avoidance |
6 |
500 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.96 [0.80, 1.15] |
4.2 Glucocorticosteroid withdrawal |
2 |
278 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.41 [0.19, 0.90] |
5 Chronic rejection |
9 |
974 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.08 [0.56, 2.10] |
5.1 Glucocorticosteroid avoidance |
6 |
586 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.82 [0.32, 2.08] |
5.2 Glucocorticosteroid withdrawal |
3 |
388 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.45 [0.55, 3.78] |
6 Glucocorticosteroid‐resistant rejection |
10 |
1020 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.14 [1.13, 4.02] |
6.1 Glucocorticosteroid avoidance |
7 |
689 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.88 [0.89, 3.98] |
6.2 Glucocorticosteroid withdrawal |
3 |
331 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.86 [0.86, 9.49] |
7 Diabetes mellitus |
12 |
1185 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.66, 0.99] |
7.1 Glucocorticosteroid avoidance |
7 |
674 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.70, 1.17] |
7.2 Glucocorticosteroid withdrawal |
5 |
511 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.68 [0.50, 0.94] |
8 CMV |
7 |
786 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.74 [0.48, 1.16] |
8.1 Glucocorticosteroid avoidance |
5 |
502 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.39, 1.49] |
8.2 Glucocorticosteroid withdrawal |
2 |
284 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.41, 1.30] |
9 HCV recurrence |
10 |
477 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.03 [0.92, 1.15] |
9.1 Glucocorticosteroid avoidance |
7 |
274 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.95 [0.84, 1.08] |
9.2 Glucocorticosteroid withdrawal |
3 |
203 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.18 [0.96, 1.44] |
10 Malignancy |
3 |
528 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.52 [0.16, 1.74] |
10.1 Glucocorticosteroid avoidance |
2 |
354 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.52 [0.13, 2.08] |
10.2 Glucocorticosteroid withdrawal |
1 |
174 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.54 [0.05, 5.80] |
11 Post‐transplant lymphoproliferative disorder |
2 |
330 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.39 [0.36, 15.95] |
11.1 Glucocorticosteroid avoidance |
1 |
156 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.0 [0.19, 21.61] |
11.2 Glucocorticosteroid withdrawal |
1 |
174 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.21 [0.13, 77.77] |
12 Renal insufficiency |
4 |
447 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.73, 1.19] |
12.1 Glucocorticosteroid avoidance |
4 |
447 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.73, 1.19] |
13 Creatinine |
4 |
309 |
Mean Difference (IV, Fixed, 95% CI) |
0.11 [0.07, 0.16] |
13.1 Glucocorticosteroid avoidance |
2 |
145 |
Mean Difference (IV, Fixed, 95% CI) |
0.15 [0.10, 0.20] |
13.2 Glucocorticosteroid withdrawal |
2 |
164 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.06 [‐0.16, 0.05] |
14 Hypertension |
10 |
1098 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.65, 0.90] |
14.1 Glucocorticosteroid avoidance |
6 |
634 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.66, 1.00] |
14.2 Glucocorticosteroid withdrawal |
4 |
464 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.71 [0.55, 0.91] |
15 Hyperlipidaemia |
4 |
400 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.38, 1.48] |
15.1 Glucocorticosteroid avoidance |
2 |
150 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.06 [0.45, 2.52] |
15.2 Glucocorticosteroid withdrawal |
2 |
250 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.44 [0.14, 1.41] |
16 Cholesterol |
6 |
611 |
Mean Difference (IV, Fixed, 95% CI) |
‐18.49 [‐22.02, ‐14.96] |
16.1 Glucocorticosteroid avoidance |
3 |
343 |
Mean Difference (IV, Fixed, 95% CI) |
‐18.33 [‐21.93, ‐14.72] |
16.2 Glucocorticosteroid withdrawal |
3 |
268 |
Mean Difference (IV, Fixed, 95% CI) |
‐22.06 [‐38.94, ‐5.18] |
17 Hypercholesterolaemia |
2 |
266 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.56 [0.32, 1.00] |
17.1 Glucocorticosteroid avoidance |
1 |
156 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.2 [0.55, 2.61] |
17.2 Glucocorticosteroid withdrawal |
1 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.21 [0.08, 0.59] |